Advances in MRI-based diagnosis of temporal lobe epilepsy: Correlating hippocampal subfield volumes with histopathology.
Andrea C EllsayGavin P WinstonPublished in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2024)
Epilepsy, affecting 0.5%-1% of the global population, presents a significant challenge with 30% of patients resistant to medical treatment. Temporal lobe epilepsy, a common cause of medically refractory epilepsy, is often caused by hippocampal sclerosis (HS). HS can be divided further by subtype, as defined by the International League Against Epilepsy (ILAE). Type 1 HS, the most prevalent form (60%-80% of all cases), is characterized by cell loss and gliosis predominantly in the subfields cornu ammonis (CA1) and CA4. Type 2 HS features cell loss and gliosis primarily in the CA1 sector, and type 3 HS features cell loss and gliosis predominantly in the CA4 subfield. This literature review evaluates studies on hippocampal subfields, exploring whether observable atrophy patterns from in vivo and ex vivo magnetic resonance imaging (MRI) scans correlate with histopathological examinations with manual or automated segmentation techniques. Our findings suggest only ex vivo 1.5 Tesla (T) or 3T MRI with manual segmentation or in vivo 7T MRI with manual or automated segmentations can consistently correlate subfield patterns with histopathologically derived ILAE-HS subtypes. In conclusion, manual and automated segmentation methods offer advantages and limitations in diagnosing ILAE-HS subtypes, with ongoing research crucial for refining hippocampal subfield segmentation techniques and enhancing clinical applicability.
Keyphrases
- temporal lobe epilepsy
- deep learning
- magnetic resonance imaging
- contrast enhanced
- convolutional neural network
- single cell
- diffusion weighted imaging
- machine learning
- computed tomography
- high throughput
- cell therapy
- magnetic resonance
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- bone marrow
- stem cells
- patient reported outcomes
- prognostic factors
- case report
- mesenchymal stem cells
- combination therapy
- replacement therapy